BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8682619)

  • 21. Role of Epstein-Barr virus in Burkitt's lymphoma.
    Takada K
    Curr Top Microbiol Immunol; 2001; 258():141-51. PubMed ID: 11443859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus (EBV) associated lesions of the head and neck.
    Boulter A; Johnson NW; Birnbaum W; Teo CG
    Oral Dis; 1996 Jun; 2(2):117-24. PubMed ID: 8957923
    [No Abstract]   [Full Text] [Related]  

  • 23. Replacement of the Epstein-Barr virus plasmid with the EBER plasmid in Burkitt's lymphoma cells.
    Maruo S; Nanbo A; Takada K
    J Virol; 2001 Oct; 75(20):9977-82. PubMed ID: 11559830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus and oncogenesis: from latent genes to tumours.
    Young LS; Murray PG
    Oncogene; 2003 Aug; 22(33):5108-21. PubMed ID: 12910248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative profiling of housekeeping and Epstein-Barr virus gene transcription in Burkitt lymphoma cell lines using an oligonucleotide microarray.
    Bernasconi M; Berger C; Sigrist JA; Bonanomi A; Sobek J; Niggli FK; Nadal D
    Virol J; 2006 Jun; 3():43. PubMed ID: 16756670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: a comparison with nasopharyngeal carcinoma in an endemic area.
    Wu SJ; Lay JD; Chen CL; Chen JY; Liu MY; Su IJ
    J Med Virol; 1996 Dec; 50(4):314-21. PubMed ID: 8950688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The LCR of EBV makes Burkitt's lymphoma endemic.
    Niller HH; Salamon D; Banati F; Schwarzmann F; Wolf H; Minarovits J
    Trends Microbiol; 2004 Nov; 12(11):495-9. PubMed ID: 15488390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel hypotheses for the roles of EBNA-1 and BHRF1 in EBV-related cancers.
    Horner D; Lewis M; Farrell PJ
    Intervirology; 1995; 38(3-4):195-205. PubMed ID: 8682617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective loss of integrated Epstein-Barr virus genomes after long-term cultivation of Burkitt's lymphoma x B-lymphoblastoid cell hybrids due to chromatin instability at the integration site.
    Wolf J; Jox A; Skarbek H; Pukrop T; Bartnitzke S; Pawlita M; Diehl V; Bullerdiek J
    Virology; 1995 Sep; 212(1):179-85. PubMed ID: 7676627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epstein-Barr virus: the first human tumor virus and its role in cancer.
    Pagano JS
    Proc Assoc Am Physicians; 1999; 111(6):573-80. PubMed ID: 10591086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic Strategies against Epstein-Barr Virus-Associated Cancers Using Proteasome Inhibitors.
    Hui KF; Tam KP; Chiang AKS
    Viruses; 2017 Nov; 9(11):. PubMed ID: 29160853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study on the effect of human herpesvirus 6 on replication of Epstein-Barr virus].
    Xia Q; Meng G; Ai Y
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1998 Aug; 33(4):235-6. PubMed ID: 11717892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of bcl-2 in Epstein-Barr virus-induced malignant conversion of Burkitt's lymphoma cell line Akata.
    Komano J; Takada K
    J Virol; 2001 Feb; 75(3):1561-4. PubMed ID: 11152530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study.
    Leong IT; Fernandes BJ; Mock D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eradication of latent Epstein-Barr virus by hydroxyurea alters the growth-transformed cell phenotype.
    Chodosh J; Holder VP; Gan YJ; Belgaumi A; Sample J; Sixbey JW
    J Infect Dis; 1998 May; 177(5):1194-201. PubMed ID: 9593003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.
    Rowe M; Kelly GL; Bell AI; Rickinson AB
    Semin Cancer Biol; 2009 Dec; 19(6):377-88. PubMed ID: 19619657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus (EBV) replication and expressions of EA-D (BMRF1 gene product), virus-specific deoxyribonuclease, and DNA polymerase in EBV-activated Akata cells.
    Daibata M; Sairenji T
    Virology; 1993 Oct; 196(2):900-4. PubMed ID: 8396819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-resolution analysis of CpG methylation and in vivo protein-DNA interactions at the alternative Epstein-Barr virus latency promoters Qp and Cp in the nasopharyngeal carcinoma cell line C666-1.
    Bakos A; Banati F; Koroknai A; Takacs M; Salamon D; Minarovits-Kormuta S; Schwarzmann F; Wolf H; Niller HH; Minarovits J
    Virus Genes; 2007 Oct; 35(2):195-202. PubMed ID: 17510783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomere size and telomerase activity in Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cell lines.
    Mochida A; Gotoh E; Senpuku H; Harada S; Kitamura R; Takahashi T; Yanagi K
    Arch Virol; 2005 Oct; 150(10):2139-50. PubMed ID: 15986178
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional role of phosphatidylinositol 3-kinase/Akt pathway on cell growth and lytic cycle of Epstein-Barr virus in the Burkitt's lymphoma cell line, P3HR-1.
    Mori T; Sairenji T
    Virus Genes; 2006 Jun; 32(3):327-34. PubMed ID: 16732486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.